Guidelines for the long-term treatment of depression

R. M A Hirschfeld, C. B. Nemeroff, D. L. Dunner, C. B. Montano, C. L. DeVane

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Depression is frequently a recurrent and sometimes a chronic illness. Unfortunately, most research on treatment has focused almost exclusively on the short-term. For example, the majority of clinical trials of medications and psychotherapeutic approaches last only 6 to 16 weeks. Relatively little research has been conducted on continuation treatment (usually 3-6 months) to prevent relapses and on maintenance treatment (6-24 months) to prevent recurrences. This paper will review continuation and maintenance phase pharmacotherapeutic trials and will make recommendations for clinical treatment of patients during these periods.

Original languageEnglish (US)
Pages (from-to)61-69
Number of pages9
JournalJournal of Clinical Psychiatry
Volume55
Issue number12 SUPPL.
StatePublished - 1994

Fingerprint

Guidelines
Recurrence
Therapeutics
Research
Chronic Disease
Maintenance
Clinical Trials

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Hirschfeld, R. M. A., Nemeroff, C. B., Dunner, D. L., Montano, C. B., & DeVane, C. L. (1994). Guidelines for the long-term treatment of depression. Journal of Clinical Psychiatry, 55(12 SUPPL.), 61-69.

Guidelines for the long-term treatment of depression. / Hirschfeld, R. M A; Nemeroff, C. B.; Dunner, D. L.; Montano, C. B.; DeVane, C. L.

In: Journal of Clinical Psychiatry, Vol. 55, No. 12 SUPPL., 1994, p. 61-69.

Research output: Contribution to journalArticle

Hirschfeld, RMA, Nemeroff, CB, Dunner, DL, Montano, CB & DeVane, CL 1994, 'Guidelines for the long-term treatment of depression', Journal of Clinical Psychiatry, vol. 55, no. 12 SUPPL., pp. 61-69.
Hirschfeld RMA, Nemeroff CB, Dunner DL, Montano CB, DeVane CL. Guidelines for the long-term treatment of depression. Journal of Clinical Psychiatry. 1994;55(12 SUPPL.):61-69.
Hirschfeld, R. M A ; Nemeroff, C. B. ; Dunner, D. L. ; Montano, C. B. ; DeVane, C. L. / Guidelines for the long-term treatment of depression. In: Journal of Clinical Psychiatry. 1994 ; Vol. 55, No. 12 SUPPL. pp. 61-69.
@article{1bccd26666e0478ab77f9f4e24ea1afb,
title = "Guidelines for the long-term treatment of depression",
abstract = "Depression is frequently a recurrent and sometimes a chronic illness. Unfortunately, most research on treatment has focused almost exclusively on the short-term. For example, the majority of clinical trials of medications and psychotherapeutic approaches last only 6 to 16 weeks. Relatively little research has been conducted on continuation treatment (usually 3-6 months) to prevent relapses and on maintenance treatment (6-24 months) to prevent recurrences. This paper will review continuation and maintenance phase pharmacotherapeutic trials and will make recommendations for clinical treatment of patients during these periods.",
author = "Hirschfeld, {R. M A} and Nemeroff, {C. B.} and Dunner, {D. L.} and Montano, {C. B.} and DeVane, {C. L.}",
year = "1994",
language = "English (US)",
volume = "55",
pages = "61--69",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "12 SUPPL.",

}

TY - JOUR

T1 - Guidelines for the long-term treatment of depression

AU - Hirschfeld, R. M A

AU - Nemeroff, C. B.

AU - Dunner, D. L.

AU - Montano, C. B.

AU - DeVane, C. L.

PY - 1994

Y1 - 1994

N2 - Depression is frequently a recurrent and sometimes a chronic illness. Unfortunately, most research on treatment has focused almost exclusively on the short-term. For example, the majority of clinical trials of medications and psychotherapeutic approaches last only 6 to 16 weeks. Relatively little research has been conducted on continuation treatment (usually 3-6 months) to prevent relapses and on maintenance treatment (6-24 months) to prevent recurrences. This paper will review continuation and maintenance phase pharmacotherapeutic trials and will make recommendations for clinical treatment of patients during these periods.

AB - Depression is frequently a recurrent and sometimes a chronic illness. Unfortunately, most research on treatment has focused almost exclusively on the short-term. For example, the majority of clinical trials of medications and psychotherapeutic approaches last only 6 to 16 weeks. Relatively little research has been conducted on continuation treatment (usually 3-6 months) to prevent relapses and on maintenance treatment (6-24 months) to prevent recurrences. This paper will review continuation and maintenance phase pharmacotherapeutic trials and will make recommendations for clinical treatment of patients during these periods.

UR - http://www.scopus.com/inward/record.url?scp=0028560322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028560322&partnerID=8YFLogxK

M3 - Article

C2 - 7814359

AN - SCOPUS:0028560322

VL - 55

SP - 61

EP - 69

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 12 SUPPL.

ER -